Antipsychotic drugs for anorexia nervosa
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To assess the effects of antipsychotic drugs (both first- and second-generation antipsychotics) compared to placebo on body weight gain, psychological symptoms, acceptability, and adverse events for people with anorexia nervosa.
Authors
- Ioannis Michopoulos (ORCID: https://orcid.org/0000-0003-3217-0218)
- Yan Luo (ORCID: https://orcid.org/0000-0002-5271-5126)
- Kazufumi Yoshida (ORCID: https://orcid.org/0000-0003-4475-8043)
- Yasushi Tsujimoto (ORCID: https://orcid.org/0000-0002-7214-5589)
- Hissei Imai (ORCID: https://orcid.org/0000-0003-3656-5188)
- Shino Kikuchi (ORCID: https://orcid.org/0000-0001-6706-4912)
- Norio Watanabe (ORCID: https://orcid.org/0000-0001-9768-993X)
- Ethan Sahker (ORCID: https://orcid.org/0000-0002-4269-4800)
- Toshi A. Furukawa (ORCID: https://orcid.org/0000-0003-2159-3776)
Institutions
- National and Kapodistrian University of Athens (GR)
- Kyoto University (JP)
- Kyoto City Hospital (JP)
- Takarazuka City Hospital (JP)
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2024-11-06
- DOI
- https://doi.org/10.1002/14651858.cd014834
- Primary Topic
- Eating Disorders and Behaviors
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Institute for Health and Care Research
- Department of Health and Social Care